PSYK Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
19:47
May 28
Dan Ahrens CIO & Portfolio Manager, AdvisorShares Bloomberg Markets
Psychedelics ETF benefits from regulatory tailwinds
The psychedelics ETF (PSYK) benefits from recent regulatory tailwinds, including an executive order from President Trump to fast-track alternative psychedelic treatments for mental health conditions. The fund holds real biotech companies with FDA trials, and the space is gaining attention, which should drive inflows and performance.
PSYK 1ST
MED

About PSYK Analyst Coverage

Buzzberg tracks PSYK across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Latest voices: Dan Ahrens.